Screening-first explainers for people comparing serious options — not psychedelic tourism content.
2026-09-06 · 9 min
Noribogaine explained: ibogaine’s active metabolite, why it appears in craving/mood discussions, oral-evidence gap, QTc context, and how it relates to IV ibogaine infusion.
Read article →2026-09-03 · 9 min
Ibogaine treatment duration explained: how long a physician-supervised IV ibogaine infusion program lasts, monitoring windows, oral-evidence gap, and aftercare—not a cure timeline.
Read article →2026-08-31 · 9 min
Ibogaine treatment resistant depression: investigational interest vs ketamine evidence maturity, oral-literature gap, QTc risk, and why there are no cure claims.
Read article →2026-08-24 · 9 min
Does insurance cover ibogaine? Usually not for Schedule I / non-FDA-approved care. Learn cash-pay realities, IV infusion context, and what to ask before deposits.
Read article →2026-08-17 · 9 min
Ibogaine electrolyte protocol explained: support IV (magnesium/fluids) vs psychoactive IV ibogaine infusion, QTc risk, and why oral research must not be blurred as IV proof.
Read article →2026-08-10 · 10 min
Ibogaine contraindications and who should not receive IV ibogaine: cardiac QTc risk, screening exclusions, oral-evidence gap, and why medical clearance is non-negotiable.
Read article →2026-08-03 · 10 min
Ibogaine vs Suboxone (buprenorphine) compared: MOUD evidence vs investigational IV ibogaine infusion, precipitated-withdrawal caution, QTc risk, oral-evidence gap.
Read article →2026-07-27 · 10 min
Ibogaine vs methadone compared honestly: MOUD evidence vs investigational IV ibogaine infusion, QTc risk, oral-literature gap, Schedule I status—no cure claims.
Read article →2026-07-20 · 12 min
Ibogaine for fentanyl: observational oral-literature interest, cardiac QTc risk, IV psychoactive infusion context, and why there is no proven cure or FDA approval.
Read article →2026-07-13 · 10 min
Ibogaine side effects include QTc prolongation/arrhythmia risk, nausea, ataxia, and prolonged intensity. IV infusion still needs monitoring; literature is mostly oral.
Read article →2026-07-06 · 9 min
Cheap ibogaine clinic risks: red flags include route opacity (oral vs IV), missing ECG/telemetry, cure guarantees, and citing oral studies as IV proof.
Read article →2026-06-29 · 9 min
Stanford-affiliated MISTIC / Cherian Nature Medicine 2024 used oral ibogaine + IV magnesium in veterans (open-label n≈30)—not IV-ibogaine proof. RCTs needed.
Read article →2026-06-22 · 10 min
Ibogaine treatment package inclusions for IV ibogaine infusion: screening, telemetry, physician oversight, support IV labeled separately, integration—and red flags.
Read article →2026-06-15 · 10 min
Ibogaine vs traditional rehab: compare setting, duration, evidence maturity, and cardiac risk. IV ibogaine infusion is not a rehab substitute or cure.
Read article →2026-06-08 · 10 min
Ibogaine ECG requirements and pre-infusion checklist: QTc review, electrolytes, meds, continuous telemetry for IV ibogaine infusion—plus oral-literature context.
Read article →2026-06-01 · 11 min
Is ibogaine legal in the US? It is Schedule I federally and not FDA-approved. Learn what that means for IV ibogaine infusion education—not legal advice.
Read article →2026-05-25 · 12 min
Ibogaine oral vs IV explained: most published studies use oral HCl (± IV magnesium support). Learn how that differs from psychoactive IV ibogaine infusion.
Read article →2026-05-18 · 12 min
Ibogaine vs ayahuasca: IV psychoactive ibogaine under MD supervision vs ceremony—chemistry, QTc vs MAOI risks, oral-evidence gap, settings.
Read article →2026-05-05 · 15 min
How to choose an ibogaine clinic: 14-point checklist for IV vs oral clarity, ECG/telemetry, MD oversight, cost transparency, and red flags.
Read article →2026-04-22 · 10 min
IV ibogaine infusion cost typically ranges ~$6k–$25k by medical tier. See what physician supervision, monitoring, and infusion care should include—and red flags.
Read article →2026-04-10 · 11 min
Ibogaine can prolong QTc and raise arrhythmia risk. Learn cardiac screening, ECG, electrolytes, continuous monitoring for IV ibogaine infusion, and oral-lit context.
Read article →2026-03-28 · 10 min
IV ibogaine infusion vs ketamine infusion: legality, evidence maturity, session design, cardiac risk—and why they share an IV journey model but are not interchangeable.
Read article →2026-03-12 · 15 min
IV ibogaine infusion is intravenous psychoactive ibogaine under physician supervision—with cardiac monitoring. Learn definition, oral-evidence gap, legality, and safety.
Read article →